NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · IEX Real-Time Price · USD
20.30
-0.28 (-1.36%)
Jul 2, 2024, 4:00 PM EDT - Market closed
NAMS Market Cap
NAMS has a market cap or net worth of $1.83 billion as of July 2, 2024. Its market cap has increased by 83.59% in one year.
Market Cap
1.83B
Enterprise Value
1.31B
1-Year Change
83.59%
Ranking
Category
Stock Price
$20.30
Market Cap Chart
Since December 9, 2020, NAMS's market cap has increased from $132.90M to $1.83B, an increase of 1,274.50%. That is a compound annual growth rate of 108.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.85B | 70.29% |
| Dec 29, 2023 | 1.09B | 28.43% |
| Dec 30, 2022 | 846.70M | 389.14% |
| Dec 31, 2021 | 173.10M | 28.99% |
| Dec 31, 2020 | 134.20M | 0.98% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.86B |
| Novavax | 1.85B |
| Amphastar Pharmaceuticals | 1.85B |
| LeMaitre Vascular | 1.83B |
| NovoCure | 1.83B |
| NeoGenomics | 1.81B |
| Syndax Pharmaceuticals | 1.81B |
| Recursion Pharmaceuticals | 1.79B |